mehmetercetin399

Where the data permit, compare chemically similar preparations across origins to assess whether geography still explains variation in pathway readouts after accounting for composition.

Suppose the cutoff is used only to select people for ambulatory monitoring: a positive result should trigger that measurement, not assign the phenotype itself. Prevalence alone cannot make the action reasonable; the 100-person example also needs prespecified sensitivity and specificity to calculate false positives and false negatives.

The supplied evidence cannot distinguish a shared pathway from parallel consequences of disease burden. The publication title identifies correlates in an exploratory study, but it does not establish covariance, temporal order, or mediation among the marker classes. A stronger pathway interpretation would require repeated measurements showing that podocyte changes precede fibrotic and cardiac changes within individuals after adjustment for kidney function and other shared causes. If those associations weaken after adjustment or lack temporal ordering, common disease burden is the more restrained interpretation.